Aquestive Therapeutics Inc
AQST
Get informed when a big investor buys or sells
+ FollowMarket Cap$467.73M
Close$
$-1.87
137.3% downside
Current Fair Value
137.3% downsideOvervalued by 137.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $467.73 Million |
|---|---|
| Enterprise Value | $405.83 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.76 |
| Beta | 1.45 |
| Outstanding Shares | 122,609,995 |
Return
| Return on Equity | 202.36% |
|---|---|
| Return on Assets | -48.83% |
| Return on Invested Capital | -52.03% |
Valuation & Multiples
| P/E Ratio | -7.72 |
|---|---|
| PEG | 11.9 |
| Price to Sales | - |
| Price to Book Ratio | -5.03 |
| Enterprise Value to Revenue | 8.07 |
| Enterprise Value to EBIT | -7.13 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -1.43 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$10.90 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
$11.42 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3452▼ 104.01% |
|---|---|
| Total Calls | 1,351,200▲ 11.97% |
| Total Puts | 466,400▼ 72.10% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 58.94%▼ 6.36% |
|---|---|
| Total Invested | $312.17M▼ 33.06% |
| Investors Holding | 186▼ 5.00% |
ESG Score
No data